COMPOUND FOR TREATMENT OF FSD

Japanese Patent JP2005350482

A

To provide a method for treating a female suffering from female sexual dysfunction (FSD), in particular female sexual arousal dysfunction (FSAD).

The method comprises delivering to the female with FSD, especially FSAD an agent that is capable of potentiating cAMP in the genital organs, wherein the agent is delivered in an amount capable of inducing potentiation of cAMP in the genital organs of the female. The agent is an inhibitor of NEP (neutral endopeptidase) (I:NEP) and is optionally mixed with a pharmaceutically acceptable carrier, diluent or excipient.

MAW GRAHAM NIGEL (GB)
WAYMAN CHRISTOPHER PETER (GB)

JP2005233224A

December 22, 2005

August 11, 2005

Click for automatic bibliography generation  

PFIZER (US)

A01K67/027; A61K31/00; A61K31/122; A61K31/137; A61K31/165; A61K31/17; A61K31/18; A61K31/19; C12N9/99; A61K31/191; A61K31/192; A61K31/195; A61K31/196; A61K31/197; A61K31/198; A61K31/215; A61K31/216; A61K31/223; A61K31/33; A61K31/34; A61K31/341; A61K31/352; A61K31/395; A61K31/40; A61K31/4015; A61K31/403; A61K31/404; A61K31/405; A61K31/41; A61K31/4164; A61K31/4166; A61K31/4184; A61K31/421; A61K31/433; A61K31/437; A61K31/438; A61K31/44; A61K31/4402; A61K31/4412; A61K31/4418; A61K31/4425; A61K31/4427; A61K31/443; A61K31/4439; A61K31/444; A61K31/453; A61K31/454; A61K31/4545; A61K31/47; A61K31/4706; A61K31/495; A61K31/496; A61K31/4985; A61K31/499; A61K31/505; A61K31/506; A61K31/517; A61K31/519; A61K31/52; A61K31/522; A61K31/53; A61K31/548; A61K31/55; A61K31/551; A61K31/553; A61K31/554; A61K31/65; A61K31/661; A61K31/675; A61K38/00; A61K38/12; A61K38/46; A61K38/55; A61K45/00; A61P5/30; A61P9/14; A61P15/00; A61P15/02; A61P15/08; A61P15/12; A61P25/02; A61P43/00; C07C233/58; C07C233/60; C07C311/51; C07D207/26; C07D207/27; C07D209/12; C07D213/64; C07D213/74; C07D213/75; C07D213/80; C07D213/85; C07D215/40; C07D223/10; C07D223/16; C07D233/72; C07D233/78; C07D239/95; C07D251/48; C07D257/06; C07D263/34; C07D267/14; C07D285/135; C07D295/02; C07D295/08; C07D307/14; C07D307/24; C07D307/54; C07D401/04; C07D401/12; C07D403/06; C07D471/14; C07D473/30; C07D473/34; C07D487/04; C07D513/04; C07K14/47; C07K14/705; C12N9/64; C12N9/88; C12N15/09; C12Q1/37; C12Q1/42; C12Q1/44; C12Q1/68; G01N33/15; G01N33/50; G01N33/53; G01N33/573; G01N33/68; A61K; (IPC1-7): A61K31/195; A61K31/196; A61K31/215; A61K31/4015; A61K31/433; A61K31/4412; A61K45/00; A61P15/00

Kazuo Shamoto
Tadashi Masui
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita
Ken Matsumoto

Previous Patent: JP2005350481

Next Patent: FOOD COMPOSITION, ORAL CAVITY COMPOSITION AND PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS OR TREATMEN...